Lv1
10 积分 2024-06-02 加入
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
1天前
已完结
Dual Antibody Treatment for Simultaneous Acute Cellular Rejection and Antibody-Mediated Rejection After Liver Transplantation: A Case Report
1个月前
已完结
A 10-year mono-center study on patients with burns ≥70% TBSA: prediction model construction and multi-center validation: retrospective cohort
6个月前
已完结
Pre-transplant Use of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Multicenter, Retrospective Cohort Study
7个月前
已完结
Pre-transplant Use of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Multicenter, Retrospective Cohort Study
7个月前
已完结
皖公网安备34019202002308
